$SOPH News
Last published 2d ago
- 2d agoSOPHSOPHiA GENETICS - 1782188 - SOPHIA GENETICS SAEarnings Call TranscriptsAll right. Good morning. I'm Doug Schenkel. It's my pleasure to welcome Jurgi, the founder and executive chairman of the board at Sophia Genetics. We also have Kellen Sanger, the VP and VP head of strategy. I can promote
- 1w agoSOPHSOPHiA GENETICS Q3 2026 Earnings Call - SOPHIA GENETICS SAEarnings Call TranscriptsGood morning. My name is Jenny, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sophia Genetics 3rd Quarter 2026 Earnings Conference Call. Following the presentation, w
- 3w agoSOPHSOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026PR NewswireBOSTON and ROLLE, Switzerland, Oct. 20, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third quarter
- 1mo agoSOPHMYGNAZNSOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score TechnologyPR NewswireBOSTON, Oct. 8, 2026 /CNW/ -- SOPHiA GENETICS (NASDAQ:SOPH) and Myriad Genetics, Inc., (NASDAQ:MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to
- 3mo agoSOPHSOPHiA GENETICS Q2 2026 Earnings Call - SOPHIA GENETICS SAEarnings Call TranscriptsGood morning. My name is Joelle, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sophia Genetics Second Quarter 2026 Earnings Conference Call. Following the presentatio
- 3mo agoSOPHSOPHiA GENETICS Reports Second Quarter 2026 ResultsPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the second quarter ended June...
- 3mo agoSOPHAZNSOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology TherapiesPR NewswireSOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting ...
- 3mo agoSOPHSOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026PR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today announced it will release its financial results for the second ...
- 4mo agoSOPHSOPHiA GENETICS Publishes Results of the 2026 Annual General MeetingPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today announced that its 2026 Annual General Meeting of shareholders ...
- 4mo agoSOPHSOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional SharesPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the closing of its previously announced underwritten ...
- 4mo agoSOPHSOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary SharesPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten ...
- 4mo agoSOPHSOPHiA GENETICS Announces Proposed Public Offering of Ordinary SharesPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the commencement of a proposed underwritten public...
- 5mo agoSOPHSOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General MeetingPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today confirmed, ahead of its 2026 Annual General Meeting (AGM)...
- 5mo agoSOPHSOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer CenterPR NewswireSOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer...
- 6mo agoSOPHSynnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.PR NewswireSOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, one of England's...
- 6mo agoSOPHSOPHiA GENETICS - Q1 2026 Earnings CallSOPHIA GENETICS SAEarnings Call TranscriptsGood morning. My name is Vincent, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Sophia Genetics First Quarter 2026 Earnings Conference Call. At this point, all lines ar
- 6mo agoSOPHSOPHiA GENETICS Reports First Quarter 2026 ResultsPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today reported financial results for the first quarter ended March...
- 6mo agoSOPHSOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026PR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the first...
- 6mo agoSOPHMount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026PR NewswireSOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the...
- 8mo agoSOPHSOPHiA GENETICS - Q4 and Full Year 2025 Earnings CallSOPHIA GENETICS SAEarnings Call TranscriptsGood morning. My name is Angeline, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sophia Genetics 4th Quarter and Full Year 2025 Earnings Conference Call. At this poin
- 8mo agoSOPHSOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 ResultsPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the fourth quarter and fiscal...
- 8mo agoSOPHSOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care ConferencePR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced that leadership will present at TD Cowen's 46th...
- 8mo agoSOPHSOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026PR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the fourth ...
- 9mo agoSOPHSOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health SystemsPR NewswireSOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced the addition of two of the largest U.S. healthcare...
- 10mo agoSOPHSOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition PlanPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today provided preliminary unaudited financial results for the...
- 10mo agoSOPHSOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition PlanPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today provided preliminary unaudited financial results for the...
- 10mo agoSOPHSOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision OncologyPR NewswireSOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The University of Texas MD Anderson Cancer Center today...
- 11mo agoAMZNABSICERTSOPHAI Creation Engines Transform Biotech as Wellness Tech Captures Growth WavePR NewswireEquity Insider News Commentary – Major pharmaceutical companies are cutting drug discovery timelines by 30% or more through AI models that predict...
- 1y agoSOPHSOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision MedicinePR NewswireComplete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in ...
- 1y agoSOPHComplete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025PR NewswireComplete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (Nasdaq: SOPH), a global leader in ...
- 1y agoSOPHSOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision MedicinePR NewswireSOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the...
- 1y agoSOPHSOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue GuidancePR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter ended...
- 1y agoMYGNSOPHMyriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid ExecutionGlobeNewswireHighlights Third quarter 2025 revenue of $205.7 million decreased by 4% year-over-year but was flat when excluding previously discussed headwinds1 of $8.1 million, consistent with management expectations.Third quarter
- 1y agoSOPHSOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025PR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third...
- 1y agoSOPHA.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in JapanPR NewswireA.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering...
- 1y agoSOPHA.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in JapanPR NewswireA.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering...
- 1y agoSOPHSOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in OncologyPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough...
- 1y agoMYGNSOPHMyriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid BiopsyPR NewswireMyriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology ...
- 1y agoMYGNSOPHMyriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid BiopsyGlobeNewswireSALT LAKE CITY and BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (NASDAQ:SOPH), an AI technology company
- 1y agoSOPHAZNSOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate CancerPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with...
- 1y agoSOPHSOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of PathologyPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant ...
- 1y agoSOPHSOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of PathologyPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant ...
- 1y agoSOPHSOPHiA GENETICS SA (SOPH) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoSOPHSOPHiA GENETICS Reports Second Quarter 2025 ResultsPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the second...
- 1y agoSOPHSOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomesPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an...
- 1y agoSOPHSOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025PR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial...
- 1y agoSOPHSOPHiA GENETICS Reports First Quarter 2025 ResultsPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first...
- 1y agoSOPHAZNSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACRPR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today announced the expansion ...
- 1y agoSOPHSOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025PR NewswireSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial...
- 1y agoSOPHPrecision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy CapabilitiesPR NewswirePrecision for Medicine, a leading provider of drug development and commercialization services, today announced a strategic partnership with SOPHiA...